Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 2—February 2019
Research

Zika Virus IgM Detection and Neutralizing Antibody Profiles 12–19 Months after Illness Onset

Isabel GriffinComments to Author , Stacey W. Martin, Marc Fischer, Trudy V. Chambers, Olga Kosoy, Alyssa Falise, Olga Ponomareva, Leah D. Gillis, Carina Blackmore, and Reynald Jean
Author affiliations: Florida Department of Health in Miami–Dade County, Miami, Florida, USA (I. Griffin, A. Falise, O. Ponomareva, R. Jean); Centers for Disease Control and Prevention, Fort Collins, Colorado, USA (S.W. Martin, M. Fischer, T.V. Chambers, O. Kosoy); Bureau of Public Health Laboratories, Miami (L.D. Gillis); Florida Department of Health, Tallahassee, Florida, USA (C. Blackmore)

Main Article

Table 1

Demographic and clinical characteristics of confirmed Zika virus disease case-patients in Miami–Dade County, Florida, USA

Characteristic No. (%) enrolled,* n = 62 No. (%) not enrolled,* n = 290 p value†
Age group, y 0.19
1–18 2 (3) 26 (9)
19–64 54 (87) 247 (85)
>65
6 (10)
17 (6)

Sex 0.85
M 32 (52) 146 (50)
F
30 (48)
144 (50)

Race/ethnicity 0.55
Non-Hispanic white 13 (21) 41 (14)
Non-Hispanic African American 3 (5) 14 (5)
Hispanic 42 (68) 209 (72)
Unknown
4 (6)
26 (9)

Main symptoms of Zika virus disease‡ 0.88
1 of 4 2 (3) 12 (4)
2 of 4 15 (24) 78 (27)
3 of 4 32 (52) 130 (45)
4 of 4
13 (21)
69 (24)

Origin of infection 0.19
Florida 34 (55) 133 (46)
Outside Florida 28 (45) 157 (54)

*All percentages are column percentages.
†A p value <0.05 was considered statistically significant.
‡Main symptoms were defined as fever, maculopapular rash, arthralgia, and conjunctivitis.

Main Article

Page created: January 16, 2019
Page updated: January 16, 2019
Page reviewed: January 16, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external